Abstract
The effects of an intravenous (i.v.) injection of the bradykinin analog RMP-7 (100 ng/kg) were assessed in normal dogs and dogs with focal, radiation-induced brain lesions. A dose of 20 Gy was delivered to a point 0.75 cm from a removable interstitial 125I source; parameters relating to blood flow and permeability were quantified using computed tomography 2–8 weeks after irradiation. Blood flow-related endpoints included regional cerebral blood flow (rCBF), mean transit time of blood and vascular volume, while endpoints related to permeability included blood-to-brain transfer constant (Ki), brain-to-blood transfer constant and plasma volume. In unirradiated brain, an i.v. bolus of RMP-7 administered through the left cephalic vein induced a rapid and transient hypotension and a statistically significant increase in vascular volume; no alterations in any parameter related to permeability were observed. After irradiation, changes in rCBF after RMP-7 depended upon time after exposure, effects presumably due to changing morphology in the irradiated tissues. In the radiation lesions, significant increases in Ki were observed 5 minutes after injection of RMP-7, but those increases were not related to time after irradiation or alteration in blood flow-related parameters. Our results showed that RMP-7 selectively increased permeability in already damaged vasculature without affecting the extent or volume of radiation-induced vasogenic edema. These data suggest that RMP-7 may provide an effective means to enhance the delivery of compounds to an already compromised brain while not exacerbating the potential adverse effects of pre-existing vasogenic edema.
Similar content being viewed by others
References
Elliott, PJ, Hayward NJ, Dean RJ, Blunt DG, Bartus RT: Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. Cancer Res 56: 3998–4005, 1996
Groothuis DR, Fischer JR, Lapin G, Bigner DD, Vick NA: Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol 41: 164–185, 1982
Rapoport SI, Hori M, Klatzo I: Testing of a hypothesis for osmotic opening of the blood-brain barrier. Am J Physiol 223: 323–331, 1972
Neuwelt EA, Glasberg M, Frenkel E, Barnett P: Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies. Ann Neurol 14: 316–324, 1983
Neuwelt EA, Rapoport SI: Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc 43: 214–219, 1984
Neuwelt EA, Glasberg M, Diehl J, Frenkel EP, Barnett P: Osmotic blood-brain barrier disruption in the posterior fossa of the dog. J Neurosurg 55: 742–748, 1981
Neuwelt EA, Hill SA, Frenkel EP: Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurg 15: 362–366, 1984
Millay R, Klein M, Shults W, Dahlborg S, Neuwelt E: Maxulopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol 102: 626–632, 1986
Black KL: Biochemical opening of the blood-brain barrier. Adv Drug Rev 15: 37–52, 1995
Inamura T, Black KL: Bradykinin selectively opens bloodbrain barrier in tumors. J Cerebr Blood Flow Metab 14: 862–870, 1994
Nakano S, Matsukado K, Black KL: Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56: 4027–4031, 1996
Doctrow SR, Abelleira SM, Curry LA, Heller-Harrison R, Kozarich JW, Malfroy B, McCarroll LA, Morgan KG, Morrow AR, Musso GF, Smart JL, Straub JA, Turnbull B, Gloff CA: The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. JPET 271: 229–237, 1994
Straub JA, Akiyama A, Parmar P: In vitro plasma metabolism of RMP-7. Pharm Res 11: 1673–1676, 1994
Elliott PJ, Hayward NJ, Huff MR, Nagle TL, Black KL, Bartus RT: Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy. Exper Neurol 141: 214–224, 1996
Elliott PJ, Mackic JB, Graney WF, Berislav BV: Intravenous RMP-7 elevates ocular ganciclovir levels. In: Second National Conference on Human Retroviruses and Related Infections. Washington D.C., 1995.
Inamura T, Nomura T, Bartus RT, Black KL: Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. J Neurosurg 81: 752–758, 1994
Elliott PJ, Hayward NJ, Dean RL, Bartus RT: Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7. Immunopharmacology 33: 205–208, 1996
Sanovich E, Friaen PM, Dean RL, Le HQ, Brightman MW: Pathway across blood-brain barrier opened by the bradykinin agonist RMP-7. Brain Res 705: 125–135, 1995
Naess F, Roeise O, Thidemann H, Johansen T, Stadaas JO, Aasen AO: Hemodynamic and proteolytic effects of intravenous injection of purified human plasma kallikrein. Am J Physiol 263: H405–H409, 1992
Regoli D: Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system. J Cardiovasc Pharmacol 6: S401–S412, 1984
Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Malec M, Acord P, Lamborn KR, Lamb S, Ham B, Gutin PH: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24: 583–591, 1992
Sheline GE: Radiotherapy for high grade gliomas. Int J Radiat Oncol Biol Phys 18: 793–803, 1990
Sheline GE, Wara WM, Smith V: Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6: 1215–1228, 1980
Fike JR, Cann CE, Davis RL, Borcich JK, Phillips TL, Russell LB: Computed tomography analysis of the canine brain: effects of hemibrain ??irradiation. Radiat Res 99: 294–310, 1984
Fike JR, Cann CE, Phillips TL, Bernstein M, Gutin PH, Turowski K, Weaver KA, Davis RL, Higgins RJ, DaSilva V: Radiation brain damage induced by interstitial 125-I sources: a canine model evaluated by quantitative computed tomography. Neurosurg 16: 530–537, 1985
Fike JR, Cann CE, Turowski K, Higgins RJ, Chan ASL, Phillips TL, Davis RL: Radiation dose response of normal brain. Int J Radiat Oncol Biol Phys 14: 63–70, 1988
Gobbel GT, Seilhan TM, Fike KR: Cerebrovascular response after interstitial irradiation. Radiat Res 130: 236–240, 1992
Gobbel GT, Marton LJ, Lamborn K, Seilhan TM, Fike JR: Modification of radiation-induced brain injury by ?-difluoromethylornithine (DFMO). Radiat Res 128: 306–315, 1991
Gobbel GT, Cann CE, Iwamoto HS, Fike JR: Measurement of regional cerebral blood flow using ultrafast computed tomography: experimental validation. Stroke 22: 772–779, 1991
Gobbel GT, Cann CE, Fike JR: Measurement of regional cerebral blood flow using ultrafast computed tomography: theoretical aspects. Stroke 22: 768–771, 1991
Fike JR, Gobbel GT, Marton LJ, Seilhan TM: Radiation brain injury is reduced by the polyamine inhibitor ?-difluoromethylornithine (DFMO). Radiat Res 138: 99–106, 1994
Turowski K, Fike JR, Cann CE, Higgins RJ, Davis RL, Gutin PH, Phillips TL, Weaver KA: Normal brain iodine-125 radiation damage: effect of dose and irradiated volume in a canine model. Radiol 158: 833–838, 1986
Fike JR, Gobbel GT, Chou D, Wijnhoven BPL, Bellinzona M, Nakagawa M, Seilhan TM: Cellular proliferation and infiltration following interstitial irradiation of normal dog brain is altered by an inhibitor of polyamine synthesis. Int J Radiat Oncol Biol Phys 32: 1035–1045, 1995
Gobbel GT, Fike JR: A deconvolution method for evaluating indicator-dilution curves. Phys Med Biol 39: 1833–1854, 1994
Jaschke W, Gould RG, Assimakopoulos PA, Lipton MJ: Flow measurements with a high-speed computed tomography scanner. Med Phys 14: 238–243, 1987
Press WH, Flannery BP, Teukolsky SA, Vetterling WT: In: Numerical Recipes in Pascal: The Art of Scientific Computing. Cambridge, Cambridge University Press, 1989
Bartus, RT, Elliott P, Hayward N, Dean R, McEwen EL, Fisher SK: Permeability of the BBB by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system. Immunopharmacology 33: 270–278, 1996
Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL: Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39: 125–134, 1996
Groothuis DR, Lapin GD, Vriesendorp FJ, Mikhael MA, Patlak CS: A method to quantitatively measure transcapillary transport of iodinated compounds in canine brain tumors with computed tomography. J Cerebr Blood Flow Metab 11: 939–948, 1991
Axel L: Cerebral blood flow determination by rapid-sequence computed tomography. A theoretical analysis. Radiology 137: 679–686, 1980
Wahl M, Unterberg A, Baethmann A, Schilling L: Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J Cerebr Blood Flow Metab 8: 621–634, 1988
Kamiya T, Katayama Y, Kashiwagi F, Terashi A: The role of bradykinin in mediating ischemic brain edema in rats. Stroke 24: 571–575, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fike, J.R., Gobbel, G.T., Mesiwala, A.H. et al. Cerebrovascular effects of the bradykinin analog RMP-7 in normal and irradiated dog brain. J Neurooncol 37, 199–215 (1998). https://doi.org/10.1023/A:1005874206814
Issue Date:
DOI: https://doi.org/10.1023/A:1005874206814